{"id":100520,"date":"2023-11-07T17:05:00","date_gmt":"2023-11-07T17:05:00","guid":{"rendered":"https:\/\/quixnet.net\/2023\/11\/fda-approves-new-medication-for-chronic-weight-management-fda-gov\/"},"modified":"2023-11-07T17:05:00","modified_gmt":"2023-11-07T17:05:00","slug":"fda-approves-new-medication-for-chronic-weight-management-fda-gov","status":"publish","type":"post","link":"https:\/\/quixnet.net\/wpinstance\/fda-approves-new-medication-for-chronic-weight-management-fda-gov\/","title":{"rendered":"FDA Approves New Medication for Chronic Weight Management – FDA.gov"},"content":{"rendered":"
\n
    \n
  1. FDA Approves New Medication for Chronic Weight Management<\/a>FDA.gov<\/font><\/li>\n
  2. FDA approves Eli Lilly’s diabetes drug Mounjaro for obesity under new name, Zepbound<\/a>CNN<\/font><\/li>\n
  3. FDA approves Eli Lilly’s tirzepatide for weight loss, paving way for wider use of blockbuster drug<\/a>CNBC<\/font><\/li>\n
  4. FDA approves Mounjaro for weight loss<\/a>FOX 32 Chicago<\/font><\/li>\n
  5. FDA approves Eli Lilly’s Zepbound, a weight loss drug similar to Ozempic and Wegovy<\/a>NBC News<\/font><\/li>\n
  6. View Full Coverage on Google News<\/a><\/strong><\/li>\n<\/ol>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

    FDA Approves New Medication for Chronic Weight ManagementFDA.gov FDA approves Eli Lilly’s diabetes drug Mounjaro for obesity under new name, ZepboundCNN FDA approves Eli Lilly’s tirzepatide for weight loss, paving way for wider use of blockbuster drugCNBC FDA approves Mounjaro for weight lossFOX 32 Chicago FDA approves Eli Lilly’s Zepbound, a weight loss drug similar […]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_genesis_hide_title":false,"_genesis_hide_breadcrumbs":false,"_genesis_hide_singular_image":false,"_genesis_hide_footer_widgets":false,"_genesis_custom_body_class":"","_genesis_custom_post_class":"","_genesis_layout":"","footnotes":""},"categories":[6],"tags":[],"class_list":{"0":"post-100520","1":"post","2":"type-post","3":"status-publish","4":"format-standard","6":"category-business","7":"entry"},"_links":{"self":[{"href":"https:\/\/quixnet.net\/wpinstance\/wp-json\/wp\/v2\/posts\/100520","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/quixnet.net\/wpinstance\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/quixnet.net\/wpinstance\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/quixnet.net\/wpinstance\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/quixnet.net\/wpinstance\/wp-json\/wp\/v2\/comments?post=100520"}],"version-history":[{"count":0,"href":"https:\/\/quixnet.net\/wpinstance\/wp-json\/wp\/v2\/posts\/100520\/revisions"}],"wp:attachment":[{"href":"https:\/\/quixnet.net\/wpinstance\/wp-json\/wp\/v2\/media?parent=100520"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/quixnet.net\/wpinstance\/wp-json\/wp\/v2\/categories?post=100520"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/quixnet.net\/wpinstance\/wp-json\/wp\/v2\/tags?post=100520"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}